J Virol, August 1998, p. 6725-6731, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
ubo
lu,1
Institut für Klinische und Molekulare
Virologie,
Received 10 February 1998/Accepted 13 May 1998
Human herpesvirus 8 (HHV-8) is likely to be involved in the
pathogenesis of Kaposi's sarcoma (KS) and body cavity-based lymphomas (BCBLs). The HHV-8 genome is primarily in a latent state in
BCBL-derived cell lines like BCBL-1, but lytic replication can be
induced by phorbol esters (R. Renne, W. Zhang, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. E. Ganem, Nat. Med.
2:342-346, 1996). A 35- to 37-kDa glycoprotein (gp35-37) is the
polypeptide most frequently and intensively recognized by KS patient
sera on Western blots with induced BCBL-1 cells. Its apparent molecular
mass is reduced to 30 kDa by digestion with
peptide-N-glycosidase F. By searching the known HHV-8
genomic sequence for open reading frames (ORF) with the potential
to encode such a glycoprotein, an additional, HHV-8-specific reading
frame was identified adjacently to ORF K8. This ORF, termed K8.1, was
found to be transcribed primarily into a spliced mRNA encoding a
glycoprotein of 228 amino acids. Recombinant K8.1 was regularly
recognized by KS patient sera in Western blots, and
immunoaffinity-purified antibodies to recombinant K8.1 reacted with
gp35-37. This shows that the immunogenic gp35-37 is encoded by HHV-8
reading frame K8.1, which will be a useful tool for studies of HHV-8
epidemiology and pathogenesis.
*
Corresponding author. Mailing address: Institut
für Klinische und Molekulare Virologie, Universität
Erlangen-Nürnberg, Schlossgarten 4, D-91054 Erlangen, Germany.
Phone: (49)-9131-856483. Fax: (49)-9131-856599. E-mail:
neipel{at}viro.med.uni-erlangen.de.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|